Mangosteen

Garcinia mangostana pericarp contains xanthones — principally α-mangostin (up to 69.1% of total xanthones) and γ-mangostin (17.6%) — which exert antioxidant, anti-inflammatory, and anticancer activity by scavenging free radicals, inhibiting iNOS, and inducing apoptosis in cancer cell lines. Preclinical evidence demonstrates pericarp antioxidant activity 20-fold higher than the edible aril, with cytotoxicity against MCF-7 breast cancer cells reaching 69.57% at 89.1 µg/mL, though robust human clinical trial data remains limited.

Origin & History

Garcinia mangostana L. is native to the Malay Archipelago and tropical Southeast Asia, including Thailand, Malaysia, Indonesia, and the Philippines, where it thrives in humid equatorial climates with rich, well-drained soils and consistent rainfall. The tree is slow-growing, requiring 7–10 years to first fruit, and is cultivated at low elevations below 1,000 meters. It has been cultivated throughout Southeast Asia for centuries and has since been introduced to tropical regions of India, Sri Lanka, Central America, and Hawaii.

Historical & Cultural Context

Garcinia mangostana has been a staple of Southeast Asian traditional medicine for centuries, particularly in Thailand, Malaysia, and Indonesia, where the dried pericarp was prepared as decoctions or powders to treat diarrhea, dysentery, skin infections, and wounds. In Thai folk medicine, the rind was boiled in water to create a remedy for gastrointestinal complaints, while topical pastes of powdered rind were applied to infected wounds and eczematous skin lesions. The fruit earned the informal title 'Queen of Fruits' in the region, reflecting its cultural prestige as both a food and medicinal plant. Historical documentation of its use appears in traditional Malay pharmacopeias and was noted by European explorers and botanists visiting Southeast Asia from at least the 17th century onward, contributing to its introduction into tropical cultivation globally.

Health Benefits

- **Antioxidant Protection**: The pericarp's xanthones and phenolics — including chlorogenic acid, gallic acid, and quercetin — exhibit antioxidant activity roughly 20 times greater than the edible pulp (TPC 8.56 µg/mL vs. 2.64 µg/mL in aril), scavenging reactive oxygen species and reducing cellular oxidative stress.
- **Anti-Inflammatory Activity**: α-Mangostin and γ-mangostin inhibit inducible nitric oxide synthase (iNOS) and related pro-inflammatory mediators; in silico docking studies confirm high binding affinity to residues Gln257, Pro344, and Glu371 on the iNOS enzyme, supporting traditional use for inflammatory conditions.
- **Anticancer Potential**: Pericarp rind extracts demonstrate cytotoxic activity against MCF-7 breast cancer cells at 69.57% inhibition at 89.1 µg/mL, with xanthones like garcinone E and gartanine implicated in apoptosis induction and cell cycle arrest in multiple preclinical models.
- **Wound Healing Support**: Traditional Thai and Malaysian medicine employs dried pericarp preparations topically for wound healing and skin infections, a practice plausibly supported by the pericarp's antimicrobial and astringent tannin content (up to 39.52 g TAE/100 g).
- **Gastrointestinal Relief**: The pericarp has been used historically for diarrhea management in Southeast Asian folk medicine, with tannins and phenolic acids contributing astringent, antimicrobial, and intestinal motility-modulating effects.
- **Micronutrient Delivery**: Consumption of mangosteen liquid preparations significantly increased plasma vitamin B2 (riboflavin; Cmax 7.52 ± 2.72 ng/mL, P=0.022) and vitamin B5 (pantothenic acid; Cmax 48.9 ± 11.7 ng/mL, P=0.041) versus placebo in a bioavailability study in healthy volunteers.
- **Cardiovascular and Metabolic Support**: Tocopherols (total 9.9 mg/100 g dry weight, with α-tocopherol predominating), organic acids (citric acid 56.72%, quinic acid 17.99%), and isoprenylated xanthones contribute to lipid peroxidation inhibition and potential cardioprotective effects observed in preclinical models, though human confirmation is lacking.

How It Works

α-Mangostin, the dominant xanthone in Garcinia mangostana pericarp, exerts antioxidant activity through direct radical scavenging via its phenolic hydroxyl groups and inhibition of lipid peroxidation cascades, with potency far exceeding the pulp due to pericarp's concentrated phenolic matrix. Anti-inflammatory action proceeds through suppression of iNOS expression and inhibition of nitric oxide production, with molecular docking confirming high-affinity binding of xanthone derivatives to key iNOS active-site residues (Gln257, Pro344, Glu371, Hem901), thereby reducing downstream pro-inflammatory signaling. Anticancer mechanisms include induction of apoptosis and cell cycle arrest in cancer cell lines (e.g., MCF-7 breast cancer), with garcinone E and gartanine among the xanthones implicated in direct cytotoxic activity, and in silico pharmacokinetic modeling indicates favorable drug-likeness and predicted oral bioavailability for several anti-inflammatory xanthone candidates. The full complement of phenolic acids (gallic, caffeic, ferulic, p-coumaric), flavonoids (quercetin, myricetin, rutin, epicatechin), and procyanidins also modulate nuclear factor-kappa B (NF-κB) and mitogen-activated protein kinase (MAPK) pathways, amplifying both antioxidant and anti-inflammatory responses.

Scientific Research

The evidence base for Garcinia mangostana is predominantly preclinical, comprising in vitro cell culture studies and limited in vivo animal experiments, with very few published human clinical trials examining primary health endpoints. One human bioavailability study in healthy volunteers assessed an acute dose of xanthone-rich mangosteen liquid and documented significant plasma elevations in vitamins B2 (Cmax 7.52 ± 2.72 ng/mL, P=0.022) and B5 (Cmax 48.9 ± 11.7 ng/mL, P=0.041) versus placebo, though the sample size was not fully specified and primary xanthone plasma concentrations were quantified in the range of 0.4–100 ng/mL via LC-MS/MS. No large randomized controlled trials (RCTs) with clearly defined primary outcomes such as inflammation biomarker reduction, weight loss, or disease-specific endpoints have been identified in the current literature, and researchers have explicitly called for further in vivo and clinical investigation. Overall, the evidence is largely preliminary and mechanistically promising but insufficient to support definitive therapeutic claims in humans.

Clinical Summary

Human clinical data for Garcinia mangostana remains sparse, with the most substantive human study being a bioavailability trial demonstrating significant plasma uptake of vitamins B2 and B5 following acute consumption of a xanthone-rich mangosteen liquid preparation versus placebo. α-Mangostin is detectable in human plasma at concentrations of 0.4–100 ng/mL by LC-MS/MS after oral consumption, confirming gastrointestinal absorption, but the clinical relevance of these plasma levels to anti-inflammatory or anticancer endpoints has not been established in humans. No RCTs with adequate power, defined disease populations, and pre-specified primary efficacy outcomes (e.g., CRP reduction, tumor response) have been completed and published as of current review. Confidence in the clinical benefit of mangosteen supplementation for any specific human health condition must therefore be rated as low, with all promising findings limited to in vitro and animal models.

Nutritional Profile

The edible aril (pulp) of mangosteen provides modest amounts of carbohydrates, dietary fiber, vitamin C, and B vitamins, while the pericarp — the primary medicinal portion — is not consumed directly but is exceptionally rich in bioactive phytochemicals. Total phenolic content in the pericarp reaches 8.56 µg/mL (vs. 2.64 µg/mL in aril) and total flavonoids 9.64 µg/mL (vs. 6.56 µg/mL); one concentrated extract recorded 24.31 g GAE/100 g TPC and 39.52 g TAE/100 g tannins. Tocopherol content totals 9.9 mg/100 g dry weight with α-tocopherol as the predominant form; fatty acid profile includes palmitic acid (28.64% of total fatty acids); organic acids are dominated by citric acid (56.72%) and quinic acid (17.99%). Up to 68 distinct xanthones have been identified, including α-mangostin (up to 13.32% in some extracts), γ-mangostin, garcinone E, gartanine, and β-mangostin, along with anthocyanins, procyanidins, cyanidin derivatives, and a broad suite of phenolic acids (gallic, caffeic, ferulic, p-coumaric, chlorogenic, protocatechuic). Bioavailability of α-mangostin in humans is confirmed at plasma levels of 0.4–100 ng/mL post-consumption, though absorption is influenced by food matrix, extraction solvent, and formulation.

Preparation & Dosage

- **Pericarp (Rind) Powder**: Traditionally dried and powdered; used at unspecified traditional doses for diarrhea and wound application in Thai and Malaysian folk medicine.
- **Ethanolic Pericarp Extract (Standardized)**: Standardized supplements typically target α-mangostin content; MT80 solvent extraction yields approximately 54 mg/g total phenolics, representing one of the most efficient extraction methods identified.
- **Commercial Mangosteen Juice/Liquid**: Whole-fruit juices (including pericarp) commonly marketed; one clinical bioavailability study used an acute xanthone-rich mangosteen liquid dose in healthy volunteers without specifying exact volume or xanthone content per serving.
- **Encapsulated Pericarp Extract**: Commercial capsules and tablets are widely available, frequently standardized to 10–20% α-mangostin; no evidence-based effective dose for humans has been established from RCTs.
- **Topical Preparations**: Dried pericarp decoctions applied as wound dressings in traditional Southeast Asian practice; concentration and preparation methods vary widely by region.
- **Dosage Note**: No standard clinically validated supplemental dose exists; preclinical studies use extract concentrations up to 100,000 µg/mL in assays, which do not translate directly to human dosing; human safety and efficacy doses remain to be determined through controlled trials.

Synergy & Pairings

Mangosteen pericarp xanthones are theorized to exhibit enhanced anti-inflammatory effects when combined with other polyphenol-rich botanicals such as turmeric (curcumin), as both compounds independently suppress NF-κB signaling and iNOS activity, potentially producing additive or synergistic inhibition of pro-inflammatory pathways. Co-administration with piperine (black pepper extract) may improve the oral bioavailability of α-mangostin by inhibiting intestinal P-glycoprotein efflux and CYP3A4-mediated first-pass metabolism, a mechanism well-established for structurally related polyphenols. Pairing mangosteen extract with vitamin C or other hydrophilic antioxidants may complement the lipophilic radical-scavenging activity of α-mangostin, providing broader-spectrum antioxidant coverage across aqueous and lipid compartments, though direct synergy studies for this specific combination have not been published.

Safety & Interactions

In vitro cytotoxicity testing reveals that some pericarp extraction methods (notably MTE extracts) demonstrate toxicity to normal cells, whereas other preparations (MT80, MTW solvent fractions) show no cytotoxicity to normal cells at tested concentrations, indicating that safety is highly preparation-dependent. Long-term human safety data are absent, and no established maximum safe dose, no-observed-adverse-effect level (NOAEL), or tolerable upper intake level has been formally defined for human supplementation with standardized mangosteen pericarp extract. Potential drug interactions have not been systematically studied; given the inhibition of cytochrome P450 enzymes suggested for some xanthones in preclinical models, caution is theoretically warranted with anticoagulants, immunosuppressants, and drugs with narrow therapeutic indices, though clinical interaction data are unavailable. Use during pregnancy and lactation is not supported by safety evidence and is generally discouraged pending controlled studies; individuals with bleeding disorders or scheduled for surgery should exercise caution given the theoretical antiplatelet activity of xanthone-rich extracts.